Effect of surfactant agents on the release of I-125-bovine calcitonin from PLGA microspheres: In vitro in vivo study.

被引:10
作者
Diaz, RV [1 ]
Soriano, I [1 ]
Delgado, A [1 ]
Llabres, M [1 ]
Evora, C [1 ]
机构
[1] UNIV LA LAGUNA,FAC FARM,DEPT INGN QUIM & TECHNOL FARMACEUT,E-38200 LA LAGUNA,SPAIN
关键词
calcitonin; copoly (DL-lactide/glycolide); injectable microspheres; prolonged release;
D O I
10.1016/S0168-3659(96)01470-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
DL,PLGA-microspheres of I-125-Bovine calcitonin prepared by the double emulsion technique (including Tween(R)-80 in the water phase and Span(R)-60 in the oil phase of the first emulsion) were studied in vitro and in vivo. The release of I-125-bovine calcitonin was determined in vitro at 37 degrees C in isotonic phosphate buffer (pH 7.4). I-125-bovine calcitonin microspheres (5 mg) were administered under the skin on the back of Wistar rats and the radioactivity at the injection site was subsequently measured over a 6-week period. The in vivo and in vitro I-125-bovine calcitonin profiles were affected by the surfactant agents, but in vivo release was much faster than in vitro. Following injection in rats, microspheres made with Tween(R)-80 and Span(R)-60 to give a hydrophile-lypophile balance (HLB) value of 6 and 8 in the first emulsion, released 20 and 14% of the radioactivity within the first 24 h, but only 1.3 and 1.2%/day at later times (up to 6 weeks) respectively. Under these conditions, they take 8 and 10 weeks, respectively, to release the total amount of calcitonin.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 19 条
[1]   FACTORS INFLUENCING THE RELEASE OF PEPTIDES AND PROTEINS FROM BIODEGRADABLE PARENTERAL DEPOT SYSTEMS [J].
BODMER, D ;
KISSEL, T ;
TRAECHSLIN, E .
JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) :129-137
[2]   ADSORPTION OF SALMON-CALCITONIN TO PLGA MICROSPHERES [J].
CALIS, S ;
JEYANTHI, R ;
TSAI, T ;
MEHTA, RC ;
DELUCA, PP .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :1072-1076
[3]   CONFORMATIONAL REQUIREMENTS FOR ACTIVITY OF SALMON-CALCITONIN [J].
FINDLAY, DM ;
MICHELANGELI, VP ;
MARTIN, TJ ;
ORLOWSKI, RC ;
SEYLER, JK .
ENDOCRINOLOGY, 1985, 117 (03) :801-805
[4]   LIPOSOME ENTRAPMENT ENHANCES THE HYPOCALCEMIC ACTION OF PARENTERALLY ADMINISTERED CALCITONIN [J].
FUKUNAGA, M ;
MILLER, MM ;
HOSTETLER, KY ;
DEFTOS, LJ .
ENDOCRINOLOGY, 1984, 115 (02) :757-761
[5]  
Gardenton D., 1991, POLYPEPTIDE PROTEIN, P211
[6]  
KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
[7]   INVIVO ASSESSMENT OF SALMON-CALCITONIN SUSTAINED-RELEASE FROM BIODEGRADABLE MICROSPHERES [J].
LEE, KC ;
SOLTIS, EE ;
NEWMAN, PS ;
BURTON, KW ;
MEHTA, RC ;
DELUCA, PP .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (02) :199-205
[8]   NONINVASIVE MEASUREMENT OF PROTEIN RELEASE FROM SUBCUTANEOUS DEPO FORMULATIONS IN-VIVO USING X-RAY-FLUORESCENCE [J].
MACLEAN, DS ;
ROBERTSON, JD ;
JAY, M ;
STALKER, DJ .
JOURNAL OF CONTROLLED RELEASE, 1995, 34 (02) :167-173
[9]   BIODEGRADABLE MICROSPHERES AS DEPOT SYSTEM FOR PARENTERAL DELIVERY OF PEPTIDE DRUGS [J].
MEHTA, RC ;
JEYANTHI, R ;
CALIS, S ;
THANOO, BC ;
BURTON, KW ;
DELUCA, PP .
JOURNAL OF CONTROLLED RELEASE, 1994, 29 (03) :375-384
[10]   EFFECTS OF PROTEOLYTIC-ENZYME INHIBITORS ON NASAL ABSORPTION OF SALMON-CALCITONIN IN RATS [J].
MORIMOTO, K ;
MIYAZAKI, M ;
KAKEMI, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 113 (01) :1-8